CoChat

Epidermal Growth Factor Receptor-PI3K Signaling Controls Cofilin Activity To Facilitate Herpes Simplex Virus 1 Entry into Neuronal Cells

Open access

The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.

Abstract

Herpes simplex virus type 1 (HSV-1) establishes latency in neurons and can cause severe disseminated infection with neurological impairment and high mortality. This neurodegeneration is thought to be tightly associated with virus-induced cytoskeleton disruption. Currently, the regulation pattern of the actin cytoskeleton and the involved molecular mechanisms during HSV-1 entry into neurons remain unclear. Here, we demonstrate that the entry of HSV-1 into neuronal cells induces biphasic remodeling of the actin cytoskeleton and an initial inactivation followed by the subsequent activation of cofilin, a member of the actin depolymerizing factor family that is critical for actin reorganization. The disruption of F-actin dynamics or the modulation of cofilin activity by mutation, knockdown, or overexpression affects HSV-1 entry efficacy and virus-mediated cell ruffle formation. Binding of the HSV-1 envelope initiates the epidermal growth factor receptor (EGFR)-phosphatidylinositide 3-kinase (PI3K) signaling pathway, which leads to virus-induced early cofilin phosphorylation and F-actin polymerization. Moreover, the extracellular signal-regulated kinase (ERK) kinase and Rho-associated, coiled-coil-containing protein kinase 1 (ROCK) are recruited as downstream mediators of the HSV-1-induced cofilin inactivation pathway. Inhibitors specific for those kinases significantly reduce the virus infectivity without affecting virus binding to the target cells. Additionally, lipid rafts are clustered to promote EGFR-associated signaling cascade transduction. We propose that HSV-1 hijacks cofilin to initiate infection. These results could promote a better understanding of the pathogenesis of HSV-1-induced neurological diseases. IMPORTANCE The actin cytoskeleton is involved in many crucial cellular processes and acts as an obstacle to pathogen entry into host cells. Because HSV-1 establishes lifelong latency in neurons and because neuronal cytoskeletal disruption is thought to be the main cause of HSV-1-induced neurodegeneration, understanding the F-actin remodeling pattern by HSV-1 infection and the molecular interactions that facilitate HSV-1 entry into neurons is important. In this study, we showed that HSV-1 infection induces the rearrangement of the cytoskeleton as well as the initial inactivation and subsequent activation of cofilin. Then, we determined that activation of the EGFR-PI3K-Erk1/2 signaling pathway inactivates cofilin and promotes F-actin polymerization. We postulate that by regulating actin cytoskeleton dynamics, cofilin biphasic activation could represent the specific cellular machinery usurped by pathogen infection, and these results will greatly contribute to the understanding of HSV-1-induced early and complex changes in host cells that are closely linked to HSV-1 pathogenesis.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1128/mbio.00958-13

Cites

75 of 75 references verified0 citation errors · 0 not checkable

Statistics

Figures

FIG 1 HSV-1 infection induces actin cytoskeleton rearrangement and biphasic activation of cofilin. (A) Formation of cell protrusions induced by HSV-1 infection. After HSV-1 (MOI 20) attachment at 4°C for 1 h, SK–N–SH cells were shifted to 37°C for the indicated times and were then stained with TRITC-phalloidin and examined by confocal microscopy. For mock infection, the cells were placed at 4°C for 1 h without virus and then moved to 37°C for the indicated times. Scale bar = 10 µm. (B) Quantification of the changes in cell ruffles at different time points postinfection. The cells with F-actin stress fibers, lamellipodia, or filopodia were designated positive cells; each value represents the mean of the results from 50 to 80 cells from at least 5 fields of 3 representative experiments. (C) Actin polymerization and depolymerization triggered by stimulation with HSV-1. F-actin was stained with FITC-phalloidin and was analyzed by flow cytometry. Each value represents the mean ± standard deviation (SD) of the results of three separate experiments. (D to F) Cytoskeleton inhibitors inhibit HSV-1 entry in a concentration-dependent manner. The cells were pretreated with Cyto D, Lat-A, or Jas at different concentrations, and HSV-1 internalization was assessed by real-time PCR (see Materials and Methods). The data are shown as the mean percent infected ± SD for three separate experiments. (G) Entry kinetics of HSV-1. Cells challenged with HSV-1 were stained with anti-ICP5 monoclonal antibody (MAb) (green), TRITC-phalloidin (red), and DAPI (blue) at the times indicated. The graph indicates the quantification of the viral particle locations at different times. At least 50 cells from five representative fields were counted in each experiment. (H) The cells bound with HSV-1 at 4°C for 1 h were transferred to 37°C; at the indicated times, bound virions that had not entered the cells were removed, and internalized viral DNA was extracted and assayed by real-time PCR. (I) Penetration assay. The cells were infected with HSV-1 at 4°C for 2 h. At various times after transfer of the cells to 37°C, virions that had not penetrated were inactivated with a pH 3 wash, and plaques were counted after 2 days. (J) Biphasic activation of cofilin and LIMK. Cofilin inactivation was measured by Western blotting using either an MAb specific for p-cofilin or an anti-cofilin pAb at the indicated time postinfection, and LIMK activation was probed using either an MAb specific for p-LIMK or an anti-LIMK MAb. In all the mock-infected experimental groups, the untreated cells were used as a control. In the HSV-1-infected group, the cells that were incubated at 4°C for 1 h and then transferred to 37°C for indicated times without HSV-1 infection to mimic infection were used as the control (mock).
FIG 1 HSV-1 infection induces actin cytoskeleton rearrangement and biphasic activation of cofilin. (A) Formation of cell protrusions induced by HSV-1 infection. After HSV-1 (MOI 20) attachment at 4°C for 1 h, SK–N–SH cells were shifted to 37°C for the indicated times and were then stained with TRITC-phalloidin and examined by confocal microscopy. For mock infection, the cells were placed at 4°C for 1 h without virus and then moved to 37°C for the indicated times. Scale bar = 10 µm. (B) Quantification of the changes in cell ruffles at different time points postinfection. The cells with F-actin stress fibers, lamellipodia, or filopodia were designated positive cells; each value represents the mean of the results from 50 to 80 cells from at least 5 fields of 3 representative experiments. (C) Actin polymerization and depolymerization triggered by stimulation with HSV-1. F-actin was stained with FITC-phalloidin and was analyzed by flow cytometry. Each value represents the mean ± standard deviation (SD) of the results of three separate experiments. (D to F) Cytoskeleton inhibitors inhibit HSV-1 entry in a concentration-dependent manner. The cells were pretreated with Cyto D, Lat-A, or Jas at different concentrations, and HSV-1 internalization was assessed by real-time PCR (see Materials and Methods). The data are shown as the mean percent infected ± SD for three separate experiments. (G) Entry kinetics of HSV-1. Cells challenged with HSV-1 were stained with anti-ICP5 monoclonal antibody (MAb) (green), TRITC-phalloidin (red), and DAPI (blue) at the times indicated. The graph indicates the quantification of the viral particle locations at different times. At least 50 cells from five representative fields were counted in each experiment. (H) The cells bound with HSV-1 at 4°C for 1 h were transferred to 37°C; at the indicated times, bound virions that had not entered the cells were removed, and internalized viral DNA was extracted and assayed by real-time PCR. (I) Penetration assay. The cells were infected with HSV-1 at 4°C for 2 h. At various times after transfer of the cells to 37°C, virions that had not penetrated were inactivated with a pH 3 wash, and plaques were counted after 2 days. (J) Biphasic activation of cofilin and LIMK. Cofilin inactivation was measured by Western blotting using either an MAb specific for p-cofilin or an anti-cofilin pAb at the indicated time postinfection, and LIMK activation was probed using either an MAb specific for p-LIMK or an anti-LIMK MAb. In all the mock-infected experimental groups, the untreated cells were used as a control. In the HSV-1-infected group, the cells that were incubated at 4°C for 1 h and then transferred to 37°C for indicated times without HSV-1 infection to mimic infection were used as the control (mock).CC BY-NC-SA · PubMed Central
FIG 2 Role for cofilin in HSV-1-mediated membrane ruffling and entry. (A and B) HSV-1 entry is impaired by cofilin knockdown (A) or the transient overexpression of wild-type cofilin or mutants (S3A and S3E) (B). Western blot results show the knockdown or overexpression efficacy. Cells were transfected with siRNA or plasmids. At 24 h postinfection, the cells were infected with HSV-1 (MOI =20) for 1 h, and HSV-1 entry was evaluated by real-time PCR. The results are representative of three separate experiments. Ctrl, control. (C) Confocal microscopy assays showing inhibited virus entry. The cells were transfected with green fluorescent protein (GFP)-tagged plasmids (2 µg), infected with HSV-1 (MOI 20) for 1 h, fixed, and then stained with anti-ICP5 (white). Bound virions that had not entered the cells were removed by washing with cold PBS (pH 3.0). The average number of ICP5-positive capsids per nucleus was determined to evaluate viral entry. At least 50 cells with ICP5 docked at nuclei from 5 representative fields were counted in each independent experiment. (D) Active cofilin motivation during HSV-1 intracellular trafficking. The cells were infected for 60 min, stained for F-actin (red) or cofilin (green), and examined by LSM. Viral ICP5 was stained (not shown) to distinguish the infected cells from the mock-infected cells. (E) Colocalization between p-cofilin and F-actin at filopodia and lamellipodia. The cells were infected with HSV-1 and stained with either anti-p-cofilin MAb (green) or TRITC-phalloidin (red). Areas of colocalization appear yellow. (F) Overexpression of cofilin reduces the HSV-1-mediated production of cell ruffles. Cells with filopodia or lamellipodia were designated positive cells, and at least 50 cells from five representative fields were counted in each experiment.
FIG 2 Role for cofilin in HSV-1-mediated membrane ruffling and entry. (A and B) HSV-1 entry is impaired by cofilin knockdown (A) or the transient overexpression of wild-type cofilin or mutants (S3A and S3E) (B). Western blot results show the knockdown or overexpression efficacy. Cells were transfected with siRNA or plasmids. At 24 h postinfection, the cells were infected with HSV-1 (MOI =20) for 1 h, and HSV-1 entry was evaluated by real-time PCR. The results are representative of three separate experiments. Ctrl, control. (C) Confocal microscopy assays showing inhibited virus entry. The cells were transfected with green fluorescent protein (GFP)-tagged plasmids (2 µg), infected with HSV-1 (MOI 20) for 1 h, fixed, and then stained with anti-ICP5 (white). Bound virions that had not entered the cells were removed by washing with cold PBS (pH 3.0). The average number of ICP5-positive capsids per nucleus was determined to evaluate viral entry. At least 50 cells with ICP5 docked at nuclei from 5 representative fields were counted in each independent experiment. (D) Active cofilin motivation during HSV-1 intracellular trafficking. The cells were infected for 60 min, stained for F-actin (red) or cofilin (green), and examined by LSM. Viral ICP5 was stained (not shown) to distinguish the infected cells from the mock-infected cells. (E) Colocalization between p-cofilin and F-actin at filopodia and lamellipodia. The cells were infected with HSV-1 and stained with either anti-p-cofilin MAb (green) or TRITC-phalloidin (red). Areas of colocalization appear yellow. (F) Overexpression of cofilin reduces the HSV-1-mediated production of cell ruffles. Cells with filopodia or lamellipodia were designated positive cells, and at least 50 cells from five representative fields were counted in each experiment.CC BY-NC-SA · PubMed Central
FIG 3 Receptor tyrosine kinases and PI3K are involved in cofilin phosphorylation. (A) Left panel: tyrosine kinase-specific inhibitor genistein (Gen) inhibits HSV-1 entry in a concentration-dependent manner. The cells were pretreated with different concentrations of genistein, and HSV-1 entry was analyzed by quantitative RT-PCR (qRT-PCR). Right panel: Gen inhibited the phosphorylation of Akt and cofilin. The cells pretreated either with or without Gen (100 mM) were exposed to HSV-1, and the cell lysates were probed with the indicated antibodies. (B) Active receptor tyrosine kinases are recruited to the cell membrane at 4°C and dispersed upon virus entry. Monolayer cells that had been infected with HSV-1 or mock infected were stained with anti-p-Tyr at different times. (C) Association of viral particles with pTyr in infected cells. The cells infected with HSV-1 for 5 min were then fixed and processed for double-immunofluorescence analysis using anti-p-Tyr and anti-ICP5 antibodies. (D) Activation of Akt during HSV-1 entry. Active Akt was probed with a p-Akt antibody. (E) Inhibitors prevent HSV-1 entry. The cells were pretreated with PP2 (10 µM) and LY294002 (50 µM) for 1 h. For binding assays, the cells pretreated with inhibitors were incubated with virus (MOI 20) at 4°C for 1 h in the presence of inhibitors, and then the viral DNA was extracted and assayed. (F) Activation of Src family kinases. Active Akt was probed with anti-p-Src (Tyr416) MAb. (G) p-Src is recruited to the cell ledge and colocalizes with ICP5. Upper panels: cells were challenged with HSV-1 for 5 min and were stained with anti-ICP5 MAb (red) and anti-p-Src MAb (green). Lower panels: the cells were infected with HSV-1 or mock infected for 5 min and 30 min and then immunostained with anti-p-Src (Tyr416) MAb (green). (H) pTyr colocalizes with Src in the infected cells. The cells infected with HSV-1 for 30 min were immunostained with anti-p-Tyr and anti-p-Src antibodies and analyzed by confocal microscopy. PI3K staining showed no colocalization with p-Src.
FIG 3 Receptor tyrosine kinases and PI3K are involved in cofilin phosphorylation. (A) Left panel: tyrosine kinase-specific inhibitor genistein (Gen) inhibits HSV-1 entry in a concentration-dependent manner. The cells were pretreated with different concentrations of genistein, and HSV-1 entry was analyzed by quantitative RT-PCR (qRT-PCR). Right panel: Gen inhibited the phosphorylation of Akt and cofilin. The cells pretreated either with or without Gen (100 mM) were exposed to HSV-1, and the cell lysates were probed with the indicated antibodies. (B) Active receptor tyrosine kinases are recruited to the cell membrane at 4°C and dispersed upon virus entry. Monolayer cells that had been infected with HSV-1 or mock infected were stained with anti-p-Tyr at different times. (C) Association of viral particles with pTyr in infected cells. The cells infected with HSV-1 for 5 min were then fixed and processed for double-immunofluorescence analysis using anti-p-Tyr and anti-ICP5 antibodies. (D) Activation of Akt during HSV-1 entry. Active Akt was probed with a p-Akt antibody. (E) Inhibitors prevent HSV-1 entry. The cells were pretreated with PP2 (10 µM) and LY294002 (50 µM) for 1 h. For binding assays, the cells pretreated with inhibitors were incubated with virus (MOI 20) at 4°C for 1 h in the presence of inhibitors, and then the viral DNA was extracted and assayed. (F) Activation of Src family kinases. Active Akt was probed with anti-p-Src (Tyr416) MAb. (G) p-Src is recruited to the cell ledge and colocalizes with ICP5. Upper panels: cells were challenged with HSV-1 for 5 min and were stained with anti-ICP5 MAb (red) and anti-p-Src MAb (green). Lower panels: the cells were infected with HSV-1 or mock infected for 5 min and 30 min and then immunostained with anti-p-Src (Tyr416) MAb (green). (H) pTyr colocalizes with Src in the infected cells. The cells infected with HSV-1 for 30 min were immunostained with anti-p-Tyr and anti-p-Src antibodies and analyzed by confocal microscopy. PI3K staining showed no colocalization with p-Src.CC BY-NC-SA · PubMed Central
FIG 4 EGFR promotes virus entry and signaling transduction. (A) HSV-1 infection induces EGFR clustering. Cells exposed to HSV-1 for 10 min were stained with anti-p-EGFR antibody. Cells stimulated with EGF (100 ng·ml−1) were used as a control. (B) Activation of EGFR by HSV-1 infection. Left panel: Cell lysates were immunoblotted with anti-p-EGFR and anti-EGFR antibodies. Right panel: the percentages of HSV-1 entry into serum-starved SK–N–SH cells in the presence of EGF or VEGF are shown. VEGF has no effect on HSV-1 entry. The cells were pretreated with EGF, bFGF, or VEGF at different concentrations for 1 h at 37°C. (C) AG-1478 inhibits viral binding. AG-1478 was added at different times, and virus entry was assayed as before. The data are expressed relative to HSV-1 infection without compound. For the experimental setup, see Fig. S5C in the supplemental material. The right panel shows the inhibition of HSV-1 glycoprotein gB binding. Cells infected with HSV-1 for 10 min in the presence or absence of AG-1478 were lysed and probed with an anti-gB antibody. (D) The knockdown of EGFR prevents HSV-1 entry and the phosphorylation of cofilin and Akt. Five siRNAs were used, and siE4 and siE5 inhibited HSV-1 entry. (E) Cross talk between EGFR and PI3K is inhibited by Ly294002 or PP2. The cells were pretreated with AG-1478 (100 nM), PP2 (10 µM), and LY294002 (50 µM) for 1 h before infection. At 10 min after HSV-1 infection, the cell lysates were analyzed for the phosphorylation of EGFR and activation of PI3K. (F) Effect of AG-1478 on EGFR and PI3K activation. AG-1478 blocked EGF-dependent PI3K signaling. Serum-starved SK–N–SH cells were pretreated with either EGF (200 ng·ml−1) or bFGF (200 ng·ml−1) and AG-1478 (100 nM) for 60 min before infection. At 10 min after HSV-1 infection, the cell lysates were analyzed for the activation of EGFR, Akt, and cofilin. (G) AG-1478 reduces the interaction between EGFR and PI3K. Uninfected cells and cells infected with HSV-1 for 10 min in the presence or absence of AG-1478 (100 nM) were lysed and immunoprecipitated (IP) with anti-EGFR and subjected to Western blot analysis with an anti-p85 (PI3K) antibody. The bottom panel shows the blot probed with an anti-EGFR antibody.
FIG 4 EGFR promotes virus entry and signaling transduction. (A) HSV-1 infection induces EGFR clustering. Cells exposed to HSV-1 for 10 min were stained with anti-p-EGFR antibody. Cells stimulated with EGF (100 ng·ml−1) were used as a control. (B) Activation of EGFR by HSV-1 infection. Left panel: Cell lysates were immunoblotted with anti-p-EGFR and anti-EGFR antibodies. Right panel: the percentages of HSV-1 entry into serum-starved SK–N–SH cells in the presence of EGF or VEGF are shown. VEGF has no effect on HSV-1 entry. The cells were pretreated with EGF, bFGF, or VEGF at different concentrations for 1 h at 37°C. (C) AG-1478 inhibits viral binding. AG-1478 was added at different times, and virus entry was assayed as before. The data are expressed relative to HSV-1 infection without compound. For the experimental setup, see Fig. S5C in the supplemental material. The right panel shows the inhibition of HSV-1 glycoprotein gB binding. Cells infected with HSV-1 for 10 min in the presence or absence of AG-1478 were lysed and probed with an anti-gB antibody. (D) The knockdown of EGFR prevents HSV-1 entry and the phosphorylation of cofilin and Akt. Five siRNAs were used, and siE4 and siE5 inhibited HSV-1 entry. (E) Cross talk between EGFR and PI3K is inhibited by Ly294002 or PP2. The cells were pretreated with AG-1478 (100 nM), PP2 (10 µM), and LY294002 (50 µM) for 1 h before infection. At 10 min after HSV-1 infection, the cell lysates were analyzed for the phosphorylation of EGFR and activation of PI3K. (F) Effect of AG-1478 on EGFR and PI3K activation. AG-1478 blocked EGF-dependent PI3K signaling. Serum-starved SK–N–SH cells were pretreated with either EGF (200 ng·ml−1) or bFGF (200 ng·ml−1) and AG-1478 (100 nM) for 60 min before infection. At 10 min after HSV-1 infection, the cell lysates were analyzed for the activation of EGFR, Akt, and cofilin. (G) AG-1478 reduces the interaction between EGFR and PI3K. Uninfected cells and cells infected with HSV-1 for 10 min in the presence or absence of AG-1478 (100 nM) were lysed and immunoprecipitated (IP) with anti-EGFR and subjected to Western blot analysis with an anti-p85 (PI3K) antibody. The bottom panel shows the blot probed with an anti-EGFR antibody.CC BY-NC-SA · PubMed Central
FIG 5 Clustering of lipid rafts is involved in the cofilin phosphorylation signaling cascade. (A) Attachment of HSV-1 causes the clustering of plasma membrane lipids. SK–N–SH cells incubated with the FITC-conjugated cholera toxin beta subunit (CtxB) (30 µg·ml−1) were infected with HSV-1 (MOI 20), stimulated with EGF (100 ng·ml−1), or left untreated for 1 h at 4°C. The samples were then fixed and permeabilized, and images were taken by confocal microscopy. In the top view (lower panels), cells were unpermeabilized and stained with FITC-labeled CtxB under either EGF or HSV-1 stimulation. Scale bar = 10 µm. (B) Viral particles colocalize with lipid rafts. The cells incubated with FITC-conjugated CtxB (green) were bound with HSV-1 for 1 h at 4°C and then incubated at 37°C for 5 min. The samples were fixed and stained with anti-ICP5 antibody (red). (C) Cholesterol-sequestering drugs inhibit HSV-1 infection. The cells were pretreated with the indicated concentrations of methyl-β cyclodextrin or nystatin for 1 h. (D) Lipid raft interruption prevents Akt and Src activation.
FIG 5 Clustering of lipid rafts is involved in the cofilin phosphorylation signaling cascade. (A) Attachment of HSV-1 causes the clustering of plasma membrane lipids. SK–N–SH cells incubated with the FITC-conjugated cholera toxin beta subunit (CtxB) (30 µg·ml−1) were infected with HSV-1 (MOI 20), stimulated with EGF (100 ng·ml−1), or left untreated for 1 h at 4°C. The samples were then fixed and permeabilized, and images were taken by confocal microscopy. In the top view (lower panels), cells were unpermeabilized and stained with FITC-labeled CtxB under either EGF or HSV-1 stimulation. Scale bar = 10 µm. (B) Viral particles colocalize with lipid rafts. The cells incubated with FITC-conjugated CtxB (green) were bound with HSV-1 for 1 h at 4°C and then incubated at 37°C for 5 min. The samples were fixed and stained with anti-ICP5 antibody (red). (C) Cholesterol-sequestering drugs inhibit HSV-1 infection. The cells were pretreated with the indicated concentrations of methyl-β cyclodextrin or nystatin for 1 h. (D) Lipid raft interruption prevents Akt and Src activation.CC BY-NC-SA · PubMed Central
FIG 6 Erk1/2 activation controls EGFR-mediated cofilin phosphorylation and virus-induced filopodia. (A) Kinetics of Erk1/2 induction during HSV-1 early infection. Cell lysates were immunoblotted with anti-p-Erk1/2 MAb and anti-Erk1/2 antibodies. Cells of the mock group were placed at 4°C for 1 h and transferred to 37°C for 0, 10, 30, and 60 min. (B to D) The inhibition of MEK1/2 inhibits Erk1/2 activity (B), cofilin phosphorylation (C), and virus entry (D). The cells were either mock infected or infected with HSV-1 in the presence or absence of U0126 (20 µM) for different times. (E) PI3K or Src kinase is the upstream kinase of Erk1/2. The cells pretreated with PP2 (10 µM), LY294002 (50 µM), or U0126 (20 µM) were mock infected or infected with HSV-1 for 30 min, lysed, and then probed with different antibodies. (F) Recruitment of active Erk1/2 to the base of the filopodia. The cells exposed to HSV-1 or not at the indicated time were stained with anti-p-Erk1/2 (green) and TRITC-phalloidin (red). Arrows indicate the colocalization of active Erk1/2 with F-actin at the base of filopodia. (G) Erk1/2 inhibition reduces the HSV-1-mediated production of filopodia. The cells exposed to HSV-1 in the presence or absence of U0126 (20 µM) for 30 min at 37°C were examined. The graph quantifies the effect of U0126 on filopodium formation. At least 100 cells from five representative fields were counted in each experiment. (H) MLC is activated and recruited to the base of the filopodia (arrows). The cells were infected for 60 min and stained with anti-p-MLC MAb (green) or F-actin (red).
FIG 6 Erk1/2 activation controls EGFR-mediated cofilin phosphorylation and virus-induced filopodia. (A) Kinetics of Erk1/2 induction during HSV-1 early infection. Cell lysates were immunoblotted with anti-p-Erk1/2 MAb and anti-Erk1/2 antibodies. Cells of the mock group were placed at 4°C for 1 h and transferred to 37°C for 0, 10, 30, and 60 min. (B to D) The inhibition of MEK1/2 inhibits Erk1/2 activity (B), cofilin phosphorylation (C), and virus entry (D). The cells were either mock infected or infected with HSV-1 in the presence or absence of U0126 (20 µM) for different times. (E) PI3K or Src kinase is the upstream kinase of Erk1/2. The cells pretreated with PP2 (10 µM), LY294002 (50 µM), or U0126 (20 µM) were mock infected or infected with HSV-1 for 30 min, lysed, and then probed with different antibodies. (F) Recruitment of active Erk1/2 to the base of the filopodia. The cells exposed to HSV-1 or not at the indicated time were stained with anti-p-Erk1/2 (green) and TRITC-phalloidin (red). Arrows indicate the colocalization of active Erk1/2 with F-actin at the base of filopodia. (G) Erk1/2 inhibition reduces the HSV-1-mediated production of filopodia. The cells exposed to HSV-1 in the presence or absence of U0126 (20 µM) for 30 min at 37°C were examined. The graph quantifies the effect of U0126 on filopodium formation. At least 100 cells from five representative fields were counted in each experiment. (H) MLC is activated and recruited to the base of the filopodia (arrows). The cells were infected for 60 min and stained with anti-p-MLC MAb (green) or F-actin (red).CC BY-NC-SA · PubMed Central
FIG 7 ROCK is a downstream effector of Erk1/2 in HSV-1-induced early cofilin phosphorylation. (A) ROCK activation during HSV-1 entry. The cells were infected with HSV-1 (MOI 20), and the cell lysates were analyzed with an anti-ROCK antibody. The ROCK inhibitor, Y-27632 (100 µM), was used to confirm its effect on HSV-1 entry. (B) PAK1/2 is not involved in HSV-1 entry, and the PAK1/2-specific inhibitor IPA-3 (20 µM) did not affect virus entry or binding. (C) Kinase inhibitors block the activation of ROCK with no effect on PAK1/2. Inhibitor concentrations were similar to those used before. (D) Arp2/3 complex inhibitor CK548 does not affect HSV-1 entry, binding, or postentry. (E) Simple schematic of the signaling pathway involved in HSV-1-induced early cofilin phosphorylation.
FIG 7 ROCK is a downstream effector of Erk1/2 in HSV-1-induced early cofilin phosphorylation. (A) ROCK activation during HSV-1 entry. The cells were infected with HSV-1 (MOI 20), and the cell lysates were analyzed with an anti-ROCK antibody. The ROCK inhibitor, Y-27632 (100 µM), was used to confirm its effect on HSV-1 entry. (B) PAK1/2 is not involved in HSV-1 entry, and the PAK1/2-specific inhibitor IPA-3 (20 µM) did not affect virus entry or binding. (C) Kinase inhibitors block the activation of ROCK with no effect on PAK1/2. Inhibitor concentrations were similar to those used before. (D) Arp2/3 complex inhibitor CK548 does not affect HSV-1 entry, binding, or postentry. (E) Simple schematic of the signaling pathway involved in HSV-1-induced early cofilin phosphorylation.CC BY-NC-SA · PubMed Central
FIG 8 Model of cofilin regulating actin dynamics and initiating HSV-1 entry. During early infection, the virus induces cofilin inactivation and F-actin polymerization via the EGFR-PI3K-Erk1/2-ROCK-LIMK signaling pathway, which may promote receptor clustering and initiate the entry process. Lipid rafts are clustered and serve as signaling platforms for EGFR-mediated cofilin inactivation. Subsequent viral penetration requires F-actin depolymerization through cofilin activation. Thus, the biphasic activation of cofilin represents specific cellular machinery usurped by HSV-1.
FIG 8 Model of cofilin regulating actin dynamics and initiating HSV-1 entry. During early infection, the virus induces cofilin inactivation and F-actin polymerization via the EGFR-PI3K-Erk1/2-ROCK-LIMK signaling pathway, which may promote receptor clustering and initiate the entry process. Lipid rafts are clustered and serve as signaling platforms for EGFR-mediated cofilin inactivation. Subsequent viral penetration requires F-actin depolymerization through cofilin activation. Thus, the biphasic activation of cofilin represents specific cellular machinery usurped by HSV-1.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 75 references

Cited by

See all 133

Metadata

Authors
Zheng, K., Xiang, Y., Wang, X., Wang, Q., Zhong, M., Wang, S., Wang, X., Fan, J., Kitazato, K., & Wang, Y.
Affiliations
  • Jinan University (CN)
  • Sun Yat-sen University (CN)
  • Guangzhou Jinan Biomedicine Research and Development Center, National Engineering Research Center of Genetic Medicine, Jinan University, Guangzhou, People’s Republic of China
  • University of Yamanashi (JP)
  • Nagasaki University (JP)
Venue
mBio
Published
2014-02-28
Volume
5
Issue
1
Pages
e00958-13
ISSN
  • 2150-7511 (ISSN-L)
  • 2161-2129
OpenAlex
W2170752267
Cited by
118
References
75
Citations by year
2026: 5 · 2025: 5 · 2024: 9 · 2023: 14 · 2022: 18 · 2021: 9 · 2020: 13 · 2019: 5 · 2018: 13 · 2017: 4 · 2016: 5 · 2015: 8 · 2014: 10
FWCI
6.82
Type
journal article
Language
en
Open access
Licence
Locations
  • mBio (publishedVersion, cc-by-nc-sa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • Institutional Repositories DataBase (IRDB) (submittedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Nagasaki University's Academic Output SITE (Nagasaki University) (submittedVersion, cc-by-nc-nd)
Funders
  • National Science Foundation
  • National Natural Science Foundation of China
Topics
  • Health Sciences › Medicine › Infectious Diseases › Herpesvirus Infections and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
  • Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Keywords
herpes simplex virus type 1, cofilin, actin cytoskeleton remodeling, ERK1/2, ROCK1, F-actin polymerization, lipid rafts, neurodegeneration, viral latency, host-virus interaction, kinase inhibitors, antiviral therapy
MeSH terms
Actins, Cell Line, Humans, Neurons, Phosphorylation, Protein Processing, Post-Translational, Signal Transduction, Herpesvirus 1, Human, Phosphatidylinositol 3-Kinases, Actin Depolymerizing Factors, Virus Internalization, Host-Pathogen Interactions, ErbB Receptors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Epidermal Growth Factor Receptor-PI3K Signaling Controls Cofilin Activity To Facilitate Herpes Simplex Virus 1 Entry into Neuronal Cells. https://app.cochat.ai/papers/10.1128/mbio.00958-13
The paper
Zheng, K., Xiang, Y., Wang, X., Wang, Q., Zhong, M., Wang, S., Wang, X., Fan, J., Kitazato, K., & Wang, Y. (2014). Epidermal Growth Factor Receptor-PI3K Signaling Controls Cofilin Activity To Facilitate Herpes Simplex Virus 1 Entry into Neuronal Cells. mBio. https://doi.org/10.1128/mbio.00958-13

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.